450 related articles for article (PubMed ID: 7949830)
1. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome.
Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS
J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830
[TBL] [Abstract][Full Text] [Related]
2. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
Lindheim SR; Cohen MA; Chang PL; Sauer MV
J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.
Givens CR; Schriock ED; Dandekar PV; Martin MC
Fertil Steril; 1994 Nov; 62(5):1011-7. PubMed ID: 7926111
[TBL] [Abstract][Full Text] [Related]
4. Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin beta-subunit.
Yamashita T; Okamoto S; Thomas A; MacLachlan V; Healy DL
Fertil Steril; 1989 Feb; 51(2):304-9. PubMed ID: 2463940
[TBL] [Abstract][Full Text] [Related]
5. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.
Silverberg KM; Burns WN; Olive DL; Riehl RM; Schenken RS
J Clin Endocrinol Metab; 1991 Oct; 73(4):797-803. PubMed ID: 1909704
[TBL] [Abstract][Full Text] [Related]
6. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.
Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501
[TBL] [Abstract][Full Text] [Related]
7. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles.
Lin YJ; Lan KC; Huang FJ; Lin PY; Chiang HJ; Kung FT
Reprod Biol Endocrinol; 2015 May; 13():41. PubMed ID: 25967104
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between serum progesterone level at the day with human chorionic gonadotrophin administration and the outcome of pregnancy in in-vitro fertilization].
Xi QP; Mao YD; Gao Y; Ding W; Wang W; Ma X; Diao FY; Huang J; Qian XQ; Cai LB; Feng T; Yan ZJ; Liu JY
Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):118-23. PubMed ID: 20420782
[TBL] [Abstract][Full Text] [Related]
10. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.
Sharara FI; McClamrock HD
Hum Reprod; 1999 Nov; 14(11):2777-82. PubMed ID: 10548621
[TBL] [Abstract][Full Text] [Related]
11. CA-125 concentrations in the serum and pregnancy outcome in IVF cycles.
Brandenberger AW; Bersinger NA; Huber PR; Berger E; Glanzmann P; Birkhaeuser MH
J Assist Reprod Genet; 1998 Jul; 15(6):390-4. PubMed ID: 9673885
[TBL] [Abstract][Full Text] [Related]
12. Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer.
Bustillo M; Stern JJ; Coulam CB
Hum Reprod; 1995 Nov; 10(11):2862-7. PubMed ID: 8747033
[TBL] [Abstract][Full Text] [Related]
13. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
[TBL] [Abstract][Full Text] [Related]
14. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome.
Edelstein MC; Seltman HJ; Cox BJ; Robinson SM; Shaw RA; Muasher SJ
Fertil Steril; 1990 Nov; 54(5):853-7. PubMed ID: 2121554
[TBL] [Abstract][Full Text] [Related]
15. High Serum FSH is Associated with Brown Oocyte Formation and a Lower Pregnacy Rate in Human IVF Parctice.
Xu H; Deng K; Luo Q; Chen J; Zhang X; Wang X; Diao H; Zhang C
Cell Physiol Biochem; 2016; 39(2):677-84. PubMed ID: 27442586
[TBL] [Abstract][Full Text] [Related]
16. Serum progesterone at human chorionic gonadotropin injection significantly correlate with female age.
Doldi N; Persico P; De Santis L; Rabellotti E; Papaleo E; Ferrari A
Minerva Ginecol; 2005 Aug; 57(4):477-82. PubMed ID: 16170294
[TBL] [Abstract][Full Text] [Related]
17. Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization.
Legro RS; Ary BA; Paulson RJ; Stanczyk FZ; Sauer MV
Hum Reprod; 1993 Sep; 8(9):1506-11. PubMed ID: 8253943
[TBL] [Abstract][Full Text] [Related]
18. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality.
Hofmann GE; Bentzien F; Bergh PA; Garrisi GJ; Williams MC; Guzman I; Navot D
Fertil Steril; 1993 Oct; 60(4):675-9. PubMed ID: 8405524
[TBL] [Abstract][Full Text] [Related]
19. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
20. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
